Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma
by
Ratcliffe, Peter J
, Halim, Silvia
, Choudhry, Hani
, Mole, David R
, Lafleur, Véronique N
in
Cancer
/ Carcinogens
/ Carcinoma, Renal Cell - genetics
/ Cell Hypoxia - physiology
/ Chromatin
/ Competition
/ Gene expression
/ Humans
/ Hydrocarbons
/ Hypoxia
/ Hypoxia-inducible factors
/ Kidney - metabolism
/ Kidney Neoplasms - genetics
/ Kidneys
/ Ligands
/ Physiology
/ Proteins
/ Receptors, Aryl Hydrocarbon - genetics
/ Receptors, Aryl Hydrocarbon - metabolism
/ Solid tumors
/ Transcription factors
/ Tumors
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma
by
Ratcliffe, Peter J
, Halim, Silvia
, Choudhry, Hani
, Mole, David R
, Lafleur, Véronique N
in
Cancer
/ Carcinogens
/ Carcinoma, Renal Cell - genetics
/ Cell Hypoxia - physiology
/ Chromatin
/ Competition
/ Gene expression
/ Humans
/ Hydrocarbons
/ Hypoxia
/ Hypoxia-inducible factors
/ Kidney - metabolism
/ Kidney Neoplasms - genetics
/ Kidneys
/ Ligands
/ Physiology
/ Proteins
/ Receptors, Aryl Hydrocarbon - genetics
/ Receptors, Aryl Hydrocarbon - metabolism
/ Solid tumors
/ Transcription factors
/ Tumors
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma
by
Ratcliffe, Peter J
, Halim, Silvia
, Choudhry, Hani
, Mole, David R
, Lafleur, Véronique N
in
Cancer
/ Carcinogens
/ Carcinoma, Renal Cell - genetics
/ Cell Hypoxia - physiology
/ Chromatin
/ Competition
/ Gene expression
/ Humans
/ Hydrocarbons
/ Hypoxia
/ Hypoxia-inducible factors
/ Kidney - metabolism
/ Kidney Neoplasms - genetics
/ Kidneys
/ Ligands
/ Physiology
/ Proteins
/ Receptors, Aryl Hydrocarbon - genetics
/ Receptors, Aryl Hydrocarbon - metabolism
/ Solid tumors
/ Transcription factors
/ Tumors
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma
Journal Article
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma
2023
Request Book From Autostore
and Choose the Collection Method
Overview
Hypoxia-inducible factor (HIF) and aryl hydrocarbon receptor (AHR) are members of the bHLH-PAS family of transcription factors that underpin cellular responses to oxygen and to endogenous and exogenous ligands, respectively, and have central roles in the pathogenesis of renal cancer. Composed of heterodimers, they share a common HIF-1β/ARNT subunit and similar DNA-binding motifs, raising the possibility of crosstalk between the two transcriptional pathways. Here, we identify both general and locus-specific mechanisms of interaction between HIF and AHR that act both antagonistically and cooperatively. Specifically, we observe competition for the common HIF-1β/ARNT subunit, in cis synergy for chromatin binding, and overlap in their transcriptional targets. Recently, both HIF and AHR inhibitors have been developed for the treatment of solid tumours. However, inhibition of one pathway may promote the oncogenic effects of the other. Therefore, our work raises important questions as to whether combination therapy targeting both of these pro-tumourigenic pathways might show greater efficacy than targeting each system independently.
Publisher
Life Science Alliance,Life Science Alliance LLC
This website uses cookies to ensure you get the best experience on our website.